Department of Rheumatology, University of Patras Medical School, Patras, Greece.
Department of Internal Medicine, Division of Rheumatology, Patras University Hospital, Rion, 265 04, Patras, Greece.
Rheumatol Int. 2021 Jul;41(7):1203-1208. doi: 10.1007/s00296-021-04855-x. Epub 2021 Apr 12.
Research regarding renal involvement in SSc has almost exclusively focused on scleroderma renal crisis (SRC). There are relatively limited data regarding renal impairment in SSc beyond SRC. We performed an electronic search using the key words systemic sclerosis or scleroderma combined with each of the following: renal dysfunction, kidney, glomerular filtration rate (GFR), proteinuria and hematuria. We searched for reports relevant to renal dysfunction in SSc beyond SRC. In 796 SSc patients recruited in five studies. 251 (31.5%) had GFR < 90 ml/min whereas 155(19.5%) patients had GFR < 60 ml/min. Most data indicate that the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula should be considered as the most suitable tool for assessing renal function in SSc pts, since it provides similar results to measured GFR. These data indicate that renal dysfunction in SSc in not uncommon and therefore patients with SSc should have their renal function assessed by GFR estimation on a regular basis.
关于 SSc 中肾脏受累的研究几乎完全集中在硬皮病肾危象 (SRC) 上。关于 SRC 以外的 SSc 肾损害的数据相对有限。我们使用关键词系统性硬化症或硬皮病,并分别与以下每个词结合,进行了电子检索:肾功能障碍、肾脏、肾小球滤过率(GFR)、蛋白尿和血尿。我们搜索了与 SRC 以外的 SSc 肾功能障碍相关的报告。在五项研究中招募的 796 名 SSc 患者中,251 名(31.5%)患者的 GFR<90 ml/min,而 155 名(19.5%)患者的 GFR<60 ml/min。大多数数据表明,慢性肾脏病流行病学合作 (CKD-EPI) 公式应被视为评估 SSc 患者肾功能的最适用工具,因为它提供了与实测 GFR 相似的结果。这些数据表明,SSc 中的肾功能障碍并不罕见,因此 SSc 患者应定期通过 GFR 估计来评估其肾功能。